| Literature DB >> 34865269 |
Shuming Dong1, Yushan Dong1, Bin Liu1, Jing Liu1, Shikai Liu1, Zhiyu Zhao2, Wenting Li1, Boshi Tian1, Ruoxi Zhao1, Fei He1, Shili Gai1, Ying Xie3, Piaoping Yang1, Yanli Zhao4.
Abstract
Clinical applications of nanozyme-initiated chemodynamic therapy (NCDT) have been severely limited by the poor catalytic efficiency of nanozymes, insufficient endogenous hydrogen peroxide (H2 O2 ) content, and its off-target consumption. Herein, the authors developed a hollow mesoporous Mn/Zr-co-doped CeO2 tandem nanozyme (PHMZCO-AT) with regulated multi-enzymatic activities, that is, the enhancement of superoxide dismutase (SOD)-like and peroxidase (POD)-like activities and inhibition of catalase (CAT)-like activity. PHMZCO-AT as a H2 O2 homeostasis disruptor promotes H2 O2 evolution and restrains off-target elimination of H2 O2 to achieve intensive NCDT. PHMZCO-AT with SOD-like activity catalyzes endogenous superoxide anion (O2 •- ) into H2 O2 in the tumor region. The suppression of CAT activity and depletion of glutathione by PHMZCO-AT largely weaken the off-target decomposition of H2 O2 to H2 O. Elevated H2 O2 is then catalyzed by the downstream POD-like activity of PHMZCO-AT to generate toxic hydroxyl radicals, further inducing tumor apoptosis and death. T1 -weighted magnetic resonance imaging and X-ray computed tomography imaging are also achieved using PHMZCO-AT due to the existence of paramagnetic Mn2+ and the high X-ray attenuation ability of elemental Zr, permitting in vivo tracking of the therapeutic process. This work presents a typical paradigm to achieve intensive NCDT efficacy by regulating multi-enzymatic activities of nanozymes to perturb the H2 O2 homeostasis.Entities:
Keywords: cancer treatment; chemodynamic therapy; hollow cerium; homeostasis disruptor; tandem nanozymes
Mesh:
Substances:
Year: 2022 PMID: 34865269 DOI: 10.1002/adma.202107054
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849